Clinical Risk Factors for Infective Endocarditis Patients With Staphylococcus Aureus Bacteremia and the Diagnostic Utility of Transesophageal Echocardiogram.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 08 07 2022
accepted: 17 07 2022
pubmed: 24 7 2022
medline: 28 9 2022
entrez: 23 7 2022
Statut: ppublish

Résumé

Approximately 25% of patients with staphylococcus aureus bacteremia (SAB) develop infective endocarditis (IE), which has a consequent mortality of 25-46%. Current guidelines recommend routine transthoracic echocardiography (TTE) for patients with SAB; transesophageal echocardiogram (TEE) is reserved for those in whom initial TTE is negative and clinical suspicion for IE remains high. We sought to elucidate high risk features of SAB associated with the development of IE that warrant a TEE after a negative TTE. This retrospective study included 213 patients who were diagnosed with SAB at the University of New Mexico Hospital between 2010-2020. A pre-determined list of clinical risk factors along with TTE and TEE status was extracted from the electronic medical record. The primary outcome was development of IE in patients with SAB. Multivariate logistic regression analysis was used to identify clinical risk factors for IE. Moreover, sensitivity and specificity of TTE and TEE was calculated. Out of 213 patients with SAB, 68 patients met diagnostic criteria for IE. Most patients (n = 209) underwent TTE and 171 patients underwent subsequent TEE. The overall sensitivity of TTE was 63% and overall sensitivity of TEE was 88%. Multivariate analysis showed significantly increased risk of IE in patients who had implanted permanent pacemaker (aOR 32.3, CI 5.23 - 281, p < 0.001) and persistent fever (aOR 6.97, CI 2.42 - 21.0 P < 0.001). Based on our analysis, we recommend that TEE should be strongly considered after negative TTE in SAB patients with intracardiac prosthetics or persistent fever despite appropriate antibiotic therapy.

Identifiants

pubmed: 35870547
pii: S0146-2806(22)00228-6
doi: 10.1016/j.cpcardiol.2022.101331
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101331

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Umair Aslam Khan (UA)

Division of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM.

Syeda Humna Zaidi (SH)

Division of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan.

Harris Majeed (H)

Division of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM.

Erick Lopez (E)

Division of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM.

Davood Tofighi (D)

Department of Biostatistics, Epidemiology, and Research Design Support, University of New Mexico Health Sciences Center, NM.

Paul Andre (P)

Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Alex Schevchuck (A)

Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Mark E Garcia (ME)

Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Abu Baker Sheikh (AB)

Division of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM.

Veena Raizada (V)

Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM.

Rahul Sheikhar (R)

Division of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM.

Shazib Sagheer (S)

Division of Cardiology, University of New Mexico Health Sciences Center, Albuquerque, NM. Electronic address: Ssagheer@salud.unm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH